# Transcriptomic Analysis of BRAFV600E Melanoma Cells Treated with Vemurafenib (GSE42872)

> Analysis of transcriptional changes in A375 melanoma cells after vemurafenib treatment using microarray dataset GSE42872.

## 🎯 Purpose
This project analyzes the transcriptional response of BRAFV600E-mutated melanoma cells (A375) to vemurafenib treatment, using microarray data.

## 🧬 Dataset
- **GEO accession**: [GSE42872](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42872)
- **Context**: Vemurafenib is a BRAF inhibitor used to treat melanomas with BRAFV600E mutation.
- **Description**: Dataset captures gene expression before and after treatment to identify how vemurafenib alters transcription.

## 🔬 Key Findings
KEGG pathway analysis of upregulated genes revealed enrichment in:
- `p53 signaling pathway`
- `MicroRNAs in cancer`
- `Transcriptional misregulation in cancer`
- `Prostate cancer`

### Upregulated genes of interest:
- `NUPR1`, `CD36`, `MOXD1`, `DCT`, `ST6GALNAC2`

These genes are associated with:
- Apoptosis and stress response (via **p53**)
- Epigenetic and transcriptional dysregulation
- miRNA pathway involvement
- Potential links to broader oncogenic processes

## 📊 Visuals
- ✅ Heatmap of DEGs  
- ✅ KEGG barplot  


## 🧪 Tools Used
- R / Bioconductor  
- GEOquery, limma, clusterProfiler, ggplot2

## 📁 Structure
# Transcriptomic Analysis of BRAFV600E Melanoma Cells Treated with Vemurafenib (GSE42872)

> Analysis of transcriptional changes in A375 melanoma cells after vemurafenib treatment using microarray dataset GSE42872.

## 🎯 Purpose
This project analyzes the transcriptional response of BRAFV600E-mutated melanoma cells (A375) to vemurafenib treatment, using microarray data.

## 🧬 Dataset
- **GEO accession**: [GSE42872](https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42872)
- **Context**: Vemurafenib is a BRAF inhibitor used to treat melanomas with BRAFV600E mutation.
- **Description**: Dataset captures gene expression before and after treatment to identify how vemurafenib alters transcription.

## 🔬 Key Findings
KEGG pathway analysis of upregulated genes revealed enrichment in:
- `p53 signaling pathway`
- `MicroRNAs in cancer`
- `Transcriptional misregulation in cancer`
- `Prostate cancer`

### Upregulated genes of interest:
- `NUPR1`, `CD36`, `MOXD1`, `DCT`, `ST6GALNAC2`

These genes are associated with:
- Apoptosis and stress response (via **p53**)
- Epigenetic and transcriptional dysregulation
- miRNA pathway involvement
- Potential links to broader oncogenic processes

## 📊 Visuals
- ✅ Heatmap of DEGs  
- ✅ KEGG barplot  


## 🧪 Tools Used
- R / Bioconductor  
- GEOquery, limma, clusterProfiler, ggplot2

## 📁 Structure

